FUMAPHARM AG has a total of 168 patent applications. Its first patent ever was published in 1998. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are DEPRENYL ANIMAL HEALTH INC, ADVANCED MEDICINE RES INST and FX LIFE SCIENCES INTERNAT GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 12 | |
#2 | Canada | 11 | |
#3 | EPO (European Patent Office) | 10 | |
#4 | Israel | 10 | |
#5 | New Zealand | 10 | |
#6 | Poland | 10 | |
#7 | United States | 9 | |
#8 | Bulgaria | 8 | |
#9 | China | 8 | |
#10 | Czechia | 8 | |
#11 | Estonia | 8 | |
#12 | Norway | 8 | |
#13 | Serbia | 8 | |
#14 | Slovakia | 8 | |
#15 | Australia | 7 | |
#16 | Brazil | 7 | |
#17 | Hungary | 6 | |
#18 | Japan | 5 | |
#19 | Mexico | 5 | |
#20 | South Africa | 4 | |
#21 | Hong Kong | 3 | |
#22 | Montenegro | 2 | |
#23 | Germany | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Unspecified technologies | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Heterocyclic compounds | |
#6 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Strebel Hans-Peter | 138 |
#2 | Joshi Rajendra Kumar | 85 |
#3 | Joshi Rajendra K | 30 |
#4 | Petzelbauer Peter | 16 |
#5 | Joshi Kumar Rajendra | 14 |
#6 | Tamm Michael | 11 |
#7 | Zaugg Christian | 10 |
#8 | Joshi Rajendra | 8 |
#9 | Strebel Hans Peter | 4 |
#10 | Hans-Peter Strebel | 4 |
Publication | Filing date | Title |
---|---|---|
DE102005022845A1 | Thiosuccinic acid derivatives and their use | |
CN1829505A | The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma | |
CA2526586A1 | The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma | |
PL371892A1 | Carbocyclic and oxacarbocyclic fumaric acid oligomers | |
WO02055066A1 | Fumaric acid derivatives as nf-kappa-b inhibitors | |
YU51402A | Use of fumaric acid derivatives for treating mitochondrial diseases | |
YU29901A | The use of dialkyl fumarates | |
MXPA01003966A | Fumaric acid microtablets. | |
IL138110D0 | 6the use of fumaric acid derivatives in transplant medicine | |
CZ2001689A3 | Use of fumaric acid derivatives in transplantation medicine | |
PL341240A1 | Application of alkyl hydrofumarates in treating psoriasis, psoriatic arthritis, neurodermatitis, sectional enteritir (crohn disease) | |
SK41599A3 | Use of fumaric acid derivatives |